Where is the live CopyMark page for USPTO serial 79000361?

The live record is at https://getcopymark.com/trademark/79000361. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns PFLÜGERPLEX?

According to the public USPTO record for serial number 79000361, the listed owner(s) include: Homöopathisches Laboratorium Alexander Pflüger GmbH & Co. KG, Homöopathisches Laboratorium Alexander Pflüger GmbH & Co. KG, Homöopathisches Laboratorium Alexander Pflüger GmbH & Co. KG.

What is USPTO serial number 79000361?

Serial number 79000361 is the USPTO application identifier for the mark PFLÜGERPLEX. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover PFLÜGERPLEX?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: PFLÜGERPLEX Serial# 79000361 | status 404; last event UNDN | Trademark Info & Attorney Guidance

Q: What is the current status of PFLÜGERPLEX?

PFLÜGERPLEX (79000361) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PFLÜGERPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Homeopathic medicines, pharmaceutical preparations, healthcare preparations and nutritional additives for use in the treatment of abscess, achylia gastrica, acidosis, acne vulgaris, adiposity, adnexitis, adynamia, agranulocytosis, albuminuria, allergies, alopecia, amenorrhoea, amyotrophy, anal fissure, anal pruritus, angina pectoris, angiopathia, anosmia, anuria, anxiety, aphasia, apoplexy, appendicitis, arteriosclerosis, arthritis, arthrosis, ascites, asthenopia, back pain, bechterew's disease, blackheads, blepharitis, bronchial asthma, bronchiectasis, bronchitis, bruise, bursitis, cancer, cardiac asthma, cardiac insufficienca, chillblains, cholangitis, cholecystitis, cholelithiasis choroiditis; circulatory disorders; cirrhosis of the liver, colds, colics, colitis, concussion, conjunctivitis, constipation, contusion, impaired coronary circulation, cough and sneezing, cyctitis, decubitus ulcer, dementia, depression, dermatitis, diabetes mellitus, diarrhea, distorsion diverticulitis, duodenitis, dysmenorrhea, dyspepsia, dyspnea, dystonia, dysuria, eczema, eczema of the auditory channel, endometritis, enuresis, epicondylitis, lateral humeral, erythema, exanthema, exhaustion, extrasystoles, fainting, fatty liver, fever, fibrosis of the liver, flatulence, frostbite, frozen shoulder, gastralgia, gastritis, glomerulonephritis, gout, gravidity, hardening of the mammary gland, hayfever, headache, heartburn, hemorrhoids, hepatitis, hernia of diaphragma, inguinal hernia, incisinal hernia, herpes labialis, hordeolum, hyperacidity, hypercholesterolaemia, hyperemia, hyperhidrosis, hypermenorrhea, hypertension, hysteria, icterus, impaired hearing, impotency, infantile eczema, inflammation, inflammation of the rectum, insomnia, iritis, keratitis, laryngitis, lichens, low immunity, lumbago, luxation, lymphadenitis, mastitis, measles, meniere's disease, menorrhagia, migraine, myalgia, myopia, nausea, nephrolithiasis, nervousness, neuralgia, neurasthenia, neuritis, neurodermitis, osteoporosis, otitis externa, otitis media, ozaena, pancreatitis, paraesthesia of extremities, pemphigus, periostitis, pharyngitis, phlebitis, pneumonia, nasal polyps, prolapsus ani, prostatitis, pruritus, psoriasis, pyelitis, spasms of pylorus, retinitis, rheumatism, rhinitis, roemheld's syndrome, sciatic pain, seborrhea, shingles, sinusitis, spasms, cramps, splenitis, stomach cramps, sycosis barbae, tendopathy, tinnitus, tonsillitis, tracheitis, travel sickness, trigeminal neuralgia, ulcus cruris, ulcus duodeni, ulcus ventriculi, umbilical colics of children, ureteritis, urticaria, vaginitis, varicosis, venous congestions, vertigo, vomitus, warts, weakness of connective tissue, weakness of memory; dietary supplements for medicinal purposes, and food supplements	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 8, 2017	UNDN	UNDELIVERABLE MAIL - NO ACTION TAKEN	—
Sep 29, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Sep 29, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Dec 30, 2015	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Aug 24, 2013	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Jul 24, 2013	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Jul 25, 2012	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Nov 25, 2011	C71T	CANCELLED SECTION 71	—
Aug 31, 2007	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Apr 26, 2007	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Mar 31, 2006	FISN	FINAL DECISION PROCESSED AND SENT TO IB	—
Apr 19, 2005	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 2005	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2005	NPUB	NOTICE OF PUBLICATION	—
Nov 19, 2004	MAIL	PAPER RECEIVED	—
Nov 17, 2004	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Nov 15, 2004	FAXX	FAX RECEIVED	—
Nov 15, 2004	ALIE	ASSIGNED TO LIE	—
Nov 9, 2004	CNEA	EXAMINERS AMENDMENT MAILED	—
Nov 9, 2004	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Nov 9, 2004	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Sep 16, 2004	RFNT	REFUSAL PROCESSED BY IB	—
Jun 30, 2004	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2004	DOCK	ASSIGNED TO EXAMINER	—
Feb 9, 2004	NWAP	NEW APPLICATION ENTERED	—
Feb 5, 2004	SDRC	SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	—

PFLÜGERPLEX